Dihydromyricetin Improves High Glucose-Induced Dopaminergic Neuronal Damage by Activating AMPK-Autophagy Signaling Pathway
Experimental and Clinical Endocrinology & Diabetes · 01.11.2024 · 132 (11) · 631-641
DOI: 10.1055/a-2399-1174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.11.2024. Verfasst von Qi Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of South China Hengyang Medical School, Hengyang, China. Hauptthemen laut MEDLINE: Flavonols, Dopaminergic Neurons, Autophagy, Glucose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Hengyang Science and Technology Board, Health Commission of Hunan Province, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Introduction
In recent years, a growing number of clinical and biological studies have shown that patients with type 2 diabetes mellitus (T2DM) are at increased risk of developing Parkinson’s disease (PD). Prolonged exposure to hyperglycemia results in abnormal glucose metabolism, which in turn causes pathological changes similar to PD, leading to selective loss of dopaminergic neurons in the compact part of the substantia nigra. Dihydromyricetin (DHM) is a naturally occurring flavonoid with various biological activities including antioxidant and hepatoprotective properties. In this study, the effect of DHM on high glucose-induced dopaminergic neuronal damage was investigated.
Methods
The potential modulatory effects of DHM on high glucose-induced dopaminergic neuronal damage and its mechanism were studied.
Results
DHM ameliorated high glucose-induced dopaminergic neuronal damage and autophagy injury. Inhibition of autophagy by 3-methyladenine abrogated the beneficial effects of DHM on high glucose-induced dopaminergic neuronal damage. In addition, DHM increased levels of p-AMP-activated protein kinase (AMPK) and phosphorylated UNC51-like kinase 1. The AMPK inhibitor compound C eliminated DHM-induced autophagy and subsequently inhibited the ameliorative effects of DHM on high glucose-induced dopaminergic neuronal damage.
Discussion
DHM ameliorates high glucose-induced dopaminergic neuronal damage by activating the AMPK-autophagy pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology, University of South China Hengyang Medical School, Hengyang, China.
- Department of Pathology, Yuebei People's Hospital Affiliated to Shantou University School of Medicine, Shaoguan, China.
- Department of Social Medicine and Health Management, University of South China Hengyang Medical School, Hengyang, China.
- Department of Neurology, The Second Affiliated Hospital, University of South China Hengyang Medical School, Hengyang, China.
ORCID-Profile: Hongyan Ling
Förderung
- Hengyang Science and Technology Board
- Health Commission of Hunan Province
- Natural Science Foundation of Hunan Province
Zitieren
APA
Li, Q., Song, Z., Peng, L., Feng, S., Zhan, K., & Ling, H. (2024). Dihydromyricetin Improves High Glucose-Induced Dopaminergic Neuronal Damage by Activating AMPK-Autophagy Signaling Pathway. Experimental and Clinical Endocrinology & Diabetes, 132(11), 631-641. https://doi.org/10.1055/a-2399-1174
Vancouver
Li Q, Song Z, Peng L, Feng S, Zhan K, Ling H. Dihydromyricetin Improves High Glucose-Induced Dopaminergic Neuronal Damage by Activating AMPK-Autophagy Signaling Pathway. Experimental and Clinical Endocrinology & Diabetes. 2024;132(11):631-641. doi:10.1055/a-2399-1174
BibTeX
@article{Li2024,
author = {Li, Qi and Song, Zhenjiang and Peng, Liting and Feng, Shuidong and Zhan, Kebin and Ling, Hongyan},
title = {Dihydromyricetin Improves High Glucose-Induced Dopaminergic Neuronal Damage by Activating AMPK-Autophagy Signaling Pathway},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2024},
volume = {132},
number = {11},
pages = {631--641},
doi = {10.1055/a-2399-1174}
}
EUVIMED